ReviewNature reviews. Microbiology2026
Metabolic strategies of Enterobacteriaceae gut colonization.
Review in Nature reviews. Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Enterobacteriaceae are facultative anaerobic bacteria that commonly colonize the gut and include both commensals and diverse pathogens. They can flexibly adapt their metabolic strategy to grow in the intestinal environment. As Enterobacteriaceae blooms are linked to enteric disease and the dissemination of antibiotic resistance, a deeper understanding of the factors that drive their expansion is needed. In the healthy intestine, Enterobacteriaceae subsist on low concentrations of diet-derived and mucus-derived monosaccharides that feed glycolysis and mixed-acid fermentation. Inflammation reshapes this niche as immune-derived oxidants generate new terminal electron acceptors, such as nitrate or tetrathionate, and facilitate oxygen diffusion into the gut lumen, thereby expanding facultative anaerobes and broadening the range of usable substrates. In this Review, we discuss recent evidence across Escherichia coli, Citrobacter rodentium, Klebsiella spp. and Salmonella Typhimurium to define a conserved, monosaccharide-fuelled programme for colonization and its inflammatory remodelling. Competition with commensal bacteria for these nutrients underpins colonization resistance, and genetic differences can determine competitive fitness. Metabolism lies at the core of these ecological dynamics, and recognizing its central role will help guide the design of future therapies.
Identifiers
42629475What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.